RetaMaps

Audrey K Bialos, D.O.

Audrey K Bialos, D.O. · 2200 River Plaza Drive · Oakland, CA 94609

5.0· 5 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Audrey K Bialos, D.O., is a physician in Oakland, California, listed for weight-loss care. On Google the practice has a 5.0-star rating across 5 reviews dating back to 2024, with 1 posted in the past year. Reviewers mention a caring manner most often, along with the staff, results and the provider's knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 5 reviews
1
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-12. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 5 Google reviews. Of the 5 reviews we analyzed, 5 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Feeling listened to2 reviews

Common complaints

No negative reviews among those we analyzed.

5★
5
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

Rachel K.★★★★★2025-01-27

Dr. Bialos was kind, explained things well, and answered all my questions.

wendy m.★★★★★2025-01-04

Dr Bialos, I saw that Dr. Bialos is a professional, knowledgeable dr., and very likable person. She listened to my concerns and she addressed every question i had. She is excellent!!!

Jon-David H.★★★★★2024-12-07

I just established care with Dr. Bialos yesterday. So first time. She is amazing. Asked me many good questions about my health, my life, my family. I really felt heard and listened to! I also got blood drawn that same day. Very easy. Everyone at the facility at 500 San Pablo was great. And today, the next day, I got my blood test results. Very efficient. I'm actually excited to continue seeing Dr. Bialos and the staff. Highly recommend.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Audrey K Bialos, D.O.

Nearby providers in Oakland

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs